Our study revealed a positive correlation between the concentrations of YKL-40 in the serum and plasma in patients suffering from OSA and may help lay the groundwork for further research regarding the practical usage of YKL-40 as a biomarker. Here, CHI3L1 is linked to obstructive sleep apnea syndrome.